Literature DB >> 28303071

The Regulation of Iron Absorption and Homeostasis.

Daniel F Wallace1.   

Abstract

Iron is an essential element in biology, required for numerous cellular processes. Either too much or too little iron can be detrimental, and organisms have developed mechanisms for balancing iron within safe limits. In mammals there are no controlled mechanisms for the excretion of excess iron, hence body iron homeostasis is regulated at the sites of absorption, utilisation and recycling. This review will discuss the discoveries that have been made in the past 20 years into advancing our understanding of iron homeostasis and its regulation. The study of iron-associated disorders, such as the iron overload condition hereditary haemochromatosis and various forms of anaemia have been instrumental in increasing our knowledge in this area, as have cellular and animal model studies. The liver has emerged as the major site of systemic iron regulation, being the location where the iron regulatory hormone hepcidin is produced. Hepcidin is a negative regulator of iron absorption and recycling, achieving this by binding to the only known cellular iron exporter ferroportin and causing its internalisation and degradation, thereby reducing iron efflux from target cells and reducing serum iron levels. Much of the research in the iron metabolism field has focussed on the regulation of hepcidin and its interaction with ferroportin. The advances in this area have greatly increased our knowledge of iron metabolism and its regulation and have led to the development of novel diagnostics and therapeutics for iron-associated disorders.

Entities:  

Year:  2016        PMID: 28303071      PMCID: PMC5198508     

Source DB:  PubMed          Journal:  Clin Biochem Rev        ISSN: 0159-8090


  119 in total

1.  A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.

Authors:  O T Njajou; N Vaessen; M Joosse; B Berghuis; J W van Dongen; M H Breuning; P J Snijders; W P Rutten; L A Sandkuijl; B A Oostra; C M van Duijn; P Heutink
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

2.  Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis.

Authors:  Emilio Ramos; Piotr Ruchala; Julia B Goodnough; Léon Kautz; Gloria C Preza; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

3.  Regulation of hepcidin transcription by interleukin-1 and interleukin-6.

Authors:  Pauline Lee; Hongfan Peng; Terri Gelbart; Lei Wang; Ernest Beutler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-31       Impact factor: 11.205

4.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation.

Authors:  Gaël Nicolas; Caroline Chauvet; Lydie Viatte; Jean Louis Danan; Xavier Bigard; Isabelle Devaux; Carole Beaumont; Axel Kahn; Sophie Vaulont
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

5.  Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload.

Authors:  Martha P Mims; Yongli Guan; Dagmar Pospisilova; Monika Priwitzerova; Karel Indrak; Prem Ponka; Vladimir Divoky; Josef T Prchal
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

Review 6.  Non-HFE haemochromatosis.

Authors:  Daniel-F Wallace; V-Nathan Subramaniam
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

7.  Population screening for hemochromatosis: a study in 5370 Spanish blood donors.

Authors:  Mayka Sánchez; Margarita Villa; Mercedes Ingelmo; Cristina Sanz; Miquel Bruguera; Carlos Ascaso; Rafael Oliva
Journal:  J Hepatol       Date:  2003-06       Impact factor: 25.083

8.  Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis.

Authors:  Antonella Roetto; George Papanikolaou; Marianna Politou; Federica Alberti; Domenico Girelli; John Christakis; Dimitris Loukopoulos; Clara Camaschella
Journal:  Nat Genet       Date:  2002-12-09       Impact factor: 38.330

9.  Hepcidin is decreased in TFR2 hemochromatosis.

Authors:  Elizabeta Nemeth; Antonella Roetto; Giovanni Garozzo; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

10.  The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

Authors:  Laura Silvestri; Alessia Pagani; Antonella Nai; Ivana De Domenico; Jerry Kaplan; Clara Camaschella
Journal:  Cell Metab       Date:  2008-10-30       Impact factor: 27.287

View more
  60 in total

1.  Increased DMT1 and FPN1 expression with enhanced iron absorption in ulcerative colitis human colon.

Authors:  Emily A Minor; Justin T Kupec; Andrew J Nickerson; Karthikeyan Narayanan; Vazhaikkurichi M Rajendran
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-13       Impact factor: 4.249

Review 2.  The Relationships Among Metal Homeostasis, Mitochondria, and Locus Coeruleus in Psychiatric and Neurodegenerative Disorders: Potential Pathogenetic Mechanism and Therapeutic Implications.

Authors:  Yutaka Nakagawa; Shizuo Yamada
Journal:  Cell Mol Neurobiol       Date:  2022-05-30       Impact factor: 5.046

Review 3.  Dietary iron intake, iron status, and gestational diabetes.

Authors:  Cuilin Zhang; Shristi Rawal
Journal:  Am J Clin Nutr       Date:  2017-10-25       Impact factor: 7.045

4.  Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes.

Authors:  Makan Golizeh; Kwangwon Lee; Serguei Ilchenko; Abdullah Ösme; James Bena; Rovshan G Sadygov; Sangeeta R Kashyap; Takhar Kasumov
Journal:  Free Radic Biol Med       Date:  2017-10-25       Impact factor: 7.376

Review 5.  Animal Models of Normal and Disturbed Iron and Copper Metabolism.

Authors:  Xiaoyu Wang; Michael D Garrick; James F Collins
Journal:  J Nutr       Date:  2019-12-01       Impact factor: 4.798

6.  Early-Life Neuronal-Specific Iron Deficiency Alters the Adult Mouse Hippocampal Transcriptome.

Authors:  Amanda Barks; Stephanie J B Fretham; Michael K Georgieff; Phu V Tran
Journal:  J Nutr       Date:  2018-10-01       Impact factor: 4.798

Review 7.  New Perspectives on Antimicrobial Agents: Cefiderocol.

Authors:  Erin K McCreary; Emily L Heil; Pranita D Tamma
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

Review 8.  On Iron Metabolism and Its Regulation.

Authors:  Anne-Cathrine S Vogt; Tasneem Arsiwala; Mona Mohsen; Monique Vogel; Vania Manolova; Martin F Bachmann
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 9.  The Iron Curtain: Macrophages at the Interface of Systemic and Microenvironmental Iron Metabolism and Immune Response in Cancer.

Authors:  Angela DeRosa; Avigdor Leftin
Journal:  Front Immunol       Date:  2021-04-27       Impact factor: 7.561

Review 10.  Hyperferritinemia-A Clinical Overview.

Authors:  Miriam Sandnes; Rune J Ulvik; Marta Vorland; Håkon Reikvam
Journal:  J Clin Med       Date:  2021-05-07       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.